tradingkey.logo

Check Cap Ltd

CHEK

2.280USD

-0.230-9.16%
終値 09/19, 16:00ET15分遅れの株価
13.34M時価総額
損失額直近12ヶ月PER

Check Cap Ltd

2.280

-0.230-9.16%
詳細情報 Check Cap Ltd 企業名
Check Cap Ltd is an Israel-based clinical-stage medical diagnostics company. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.
企業情報
企業コードCHEK
会社名Check Cap Ltd
上場日Feb 19, 2015
最高経営責任者「CEO」Mr. Alex Ovadia
従業員数- -
証券種類Ordinary Share
決算期末Feb 19
本社所在地29 Abba Hushi Ave.
都市
証券取引所NASDAQ Capital Market Consolidated
Israel
郵便番号3009000
電話番号97248303401
ウェブサイトhttps://check-cap.com/
企業コードCHEK
上場日Feb 19, 2015
最高経営責任者「CEO」Mr. Alex Ovadia
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Boaz Shpigelman
Mr. Boaz Shpigelman
Vice President - Research and Development
Vice President - Research and Development
1.23K
+1.49%
Mr. XiangQian (XQ) Lin
Mr. XiangQian (XQ) Lin
Independent Director
Independent Director
950.00
--
Mr. Alex Ovadia
Mr. Alex Ovadia
Chief Executive Officer
Chief Executive Officer
752.00
--
Ms. Clara Ezed
Ms. Clara Ezed
Independent Director
Independent Director
211.00
--
Mr. Steven J. Hanley
Mr. Steven J. Hanley
Chairman of the Board
Chairman of the Board
--
--
Dr. Yoav Kimchy, Ph.D.
Dr. Yoav Kimchy, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Israel Hershko
Mr. Israel Hershko
Vice President - Quality Assurance and Regulatory Affairs
Vice President - Quality Assurance and Regulatory Affairs
--
--
Mr. Yuval Yanai
Mr. Yuval Yanai
Independent Director
Independent Director
--
--
Dr. Hanit Brenner-lavie
Dr. Hanit Brenner-lavie
Vice President - Clinical Affairs
Vice President - Clinical Affairs
--
--
Mr. Dan Hilerowitz
Mr. Dan Hilerowitz
Chief Financial Officer
Chief Financial Officer
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Boaz Shpigelman
Mr. Boaz Shpigelman
Vice President - Research and Development
Vice President - Research and Development
1.23K
+1.49%
Mr. XiangQian (XQ) Lin
Mr. XiangQian (XQ) Lin
Independent Director
Independent Director
950.00
--
Mr. Alex Ovadia
Mr. Alex Ovadia
Chief Executive Officer
Chief Executive Officer
752.00
--
Ms. Clara Ezed
Ms. Clara Ezed
Independent Director
Independent Director
211.00
--
Mr. Steven J. Hanley
Mr. Steven J. Hanley
Chairman of the Board
Chairman of the Board
--
--
Dr. Yoav Kimchy, Ph.D.
Dr. Yoav Kimchy, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--
収益内訳
データなし
データなし
事業別
地域別
データなし
株主
更新時刻: Sat, Aug 30
更新時刻: Sat, Aug 30
株主統計
種類
株主統計
株主統計
比率
EquityLine Alternate Assets GP Inc
10.86%
Ramanathan (Vijay)
5.13%
Symetryx Corp
4.82%
Citadel Advisors LLC
0.44%
Susquehanna International Group, LLP
0.39%
他の
78.35%
株主統計
株主統計
比率
EquityLine Alternate Assets GP Inc
10.86%
Ramanathan (Vijay)
5.13%
Symetryx Corp
4.82%
Citadel Advisors LLC
0.44%
Susquehanna International Group, LLP
0.39%
他の
78.35%
種類
株主統計
比率
Corporation
16.65%
Individual Investor
6.15%
Research Firm
0.65%
Hedge Fund
0.64%
Investment Advisor
0.58%
Investment Advisor/Hedge Fund
0.20%
Bank and Trust
0.06%
他の
75.07%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
39
1.57M
26.85%
+1.07M
2025Q1
42
1.57M
26.85%
+1.00M
2024Q4
44
1.61M
27.59%
+1.15M
2024Q3
45
1.48M
25.29%
+968.05K
2024Q2
48
1.48M
25.22%
+958.50K
2024Q1
57
722.40K
12.35%
+185.59K
2023Q4
59
777.23K
13.29%
+83.98K
2023Q3
61
699.06K
11.95%
+309.38K
2023Q2
62
22.37K
0.38%
-595.96K
2023Q1
68
336.11K
6.40%
-190.75K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
EquityLine Alternate Assets GP Inc
762.72K
13.04%
+762.72K
--
Apr 05, 2024
Ramanathan (Vijay)
360.00K
6.15%
+360.00K
--
Sep 13, 2023
Symetryx Corp
338.63K
5.79%
+37.76K
+12.55%
Nov 27, 2023
Citadel Advisors LLC
20.85K
0.36%
-1.68K
-7.46%
Mar 31, 2025
BNP Paribas Securities Corp. North America
19.84K
0.34%
+6.20K
+45.46%
Mar 31, 2025
Two Sigma Investments, LP
11.48K
0.2%
+11.48K
--
Mar 31, 2025
Dimensional Fund Advisors, L.P.
8.96K
0.15%
--
--
Jan 31, 2025
詳細を見る
関連ETF
銘柄名
比率
データなし
配当金
過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
Nov 23, 2022
Merger
20→1
Nov 23, 2022
Merger
20→1
Nov 23, 2022
Merger
20→1
Nov 23, 2022
Merger
20→1
日付
種類
比率
Nov 23, 2022
Merger
20→1
Nov 23, 2022
Merger
20→1
Nov 23, 2022
Merger
20→1
Nov 23, 2022
Merger
20→1
KeyAI